126 related articles for article (PubMed ID: 7620523)
1. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease.
Armstrong RA
Dementia; 1995; 6(3):121-5. PubMed ID: 7620523
[TBL] [Abstract][Full Text] [Related]
2. beta-Amyloid (A beta) deposition in elderly non-demented patients and patients with Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Aug; 178(1):59-62. PubMed ID: 7816341
[TBL] [Abstract][Full Text] [Related]
3. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains.
Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN
Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380
[TBL] [Abstract][Full Text] [Related]
4. beta-Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies.
Armstrong RA; Cairns NJ; Lantos PL
Neurosci Lett; 1997 May; 227(3):193-6. PubMed ID: 9185683
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease.
Armstrong RA; Cairns NJ; Lantos PL
Dement Geriatr Cogn Disord; 2000; 11(4):187-92. PubMed ID: 10867443
[TBL] [Abstract][Full Text] [Related]
6. The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.
Armstrong RA; Myers D; Smith CU
Acta Neuropathol; 1993; 86(1):36-41. PubMed ID: 8372640
[TBL] [Abstract][Full Text] [Related]
7. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
8. Quantitative differences in beta/A4 protein subtypes in the parahippocampal gyrus and frontal cortex in Alzheimer's disease.
Armstrong RA
Dementia; 1994; 5(1):1-5. PubMed ID: 8156080
[TBL] [Abstract][Full Text] [Related]
9. Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease.
Gentleman SM; Allsop D; Bruton CJ; Jagoe R; Polak JM; Roberts GW
Neurosci Lett; 1992 Feb; 136(1):27-30. PubMed ID: 1635663
[TBL] [Abstract][Full Text] [Related]
10. The spatial patterns of beta/A4 deposit subtypes in Down's syndrome.
Amstrong RA
Acta Neuropathol; 1994; 88(4):353-8. PubMed ID: 7839828
[TBL] [Abstract][Full Text] [Related]
11. The ratio of diffuse to mature beta/A4 deposits in Alzheimer's disease varies in cases with and without pronounced congophilic angiopathy.
Armstrong RA; Myers D; Smith CU
Dementia; 1993; 4(5):251-5. PubMed ID: 8261022
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
Mann DM; Jones D; Prinja D; Purkiss MS
Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
[TBL] [Abstract][Full Text] [Related]
13. A spatial pattern analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease.
Armstrong RA
Folia Neuropathol; 2010; 48(2):67-74. PubMed ID: 20602287
[TBL] [Abstract][Full Text] [Related]
14. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease.
Hellweg R; Gericke CA; Jendroska K; Hartung HD; Cervós-Navarro J
Int J Dev Neurosci; 1998; 16(7-8):787-94. PubMed ID: 10198825
[TBL] [Abstract][Full Text] [Related]
15. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans.
Ogeng'o JA; Cohen DL; Sayi JG; Matuja WB; Chande HM; Kitinya JN; Kimani JK; Friedland RP; Mori H; Kalaria RN
Brain Pathol; 1996 Apr; 6(2):101-7. PubMed ID: 8737923
[TBL] [Abstract][Full Text] [Related]
17. Beta-amyloid (beta/A4) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age.
Armstrong RA; Smith CU
Neurobiol Dis; 1994 Dec; 1(3):139-44. PubMed ID: 9173993
[TBL] [Abstract][Full Text] [Related]
18. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956
[TBL] [Abstract][Full Text] [Related]
19. Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.
Armstrong RA; Cairns NJ
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):248-57. PubMed ID: 20132489
[TBL] [Abstract][Full Text] [Related]
20. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.
Zhan SS; Veerhuis R; Kamphorst W; Eikelenboom P
Neurodegeneration; 1995 Sep; 4(3):291-7. PubMed ID: 8581561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
